CureDuchenne Webinar: Update on the Italfarmaco Givinostat Program

September 24, 2020

Hear from Dr. Paolo Bettica about the latest news related to Italfarmaco’s investigational therapy givinostat, which is being tested as a possible treatment for Duchenne muscular dystrophy, Becker muscular dystrophy, and a variety of other serious diseases.

Don’t miss this special chance to hear the latest updates and ask questions about the progress of the development program.

Click here to register for this event.